|
HS Code |
566114 |
| Chemical Name | 2-Bromo-4-Hydroxymethylthiazole |
| Molecular Formula | C4H4BrNOS |
| Cas Number | 18603-78-0 |
| Appearance | White to off-white solid |
| Melting Point | 82-86°C |
| Purity | Typically ≥ 95% |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Smiles | C1=C(SC(=N1)Br)CO |
| Inchi | InChI=1S/C4H4BrNOS/c5-4-7-2-3(1-6)8-4/h2,6H,1H2 |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
As an accredited 2-Bromo-4-Hydroxymethylthiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 2-Bromo-4-Hydroxymethylthiazole is supplied in a 1-gram amber glass vial with a secure screw cap and tamper-evident seal. |
| Shipping | 2-Bromo-4-Hydroxymethylthiazole is shipped in a tightly sealed container, protected from light, moisture, and incompatible substances. Transport is conducted in accordance with applicable regulations for hazardous chemicals, ensuring proper labeling and documentation. The package includes safety data sheets (SDS) and is handled by certified carriers specializing in chemical transportation. |
| Storage | 2-Bromo-4-hydroxymethylthiazole should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizing agents. Ideally, store it at 2–8°C (refrigerated). Ensure proper labeling and restrict access to trained personnel following appropriate safety regulations. |
Applications of 2-Bromo-4-Hydroxymethylthiazole in Industrial ManufacturingAs a direct producer of 2-Bromo-4-Hydroxymethylthiazole, we support multiple specialty chemical verticals that require precise molecular intermediates for regulated and process-intensive downstream synthesis. Our production knowledge ensures reliable batch consistency for the following key sectors. 1. Pharmaceutical Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical manufacturers utilize 2-Bromo-4-Hydroxymethylthiazole as a crucial thiazole ring-building block during the synthesis of novel heterocyclic APIs, including kinase inhibitors and CNS-active agents. High chemical purity is mandated for final step couplings and protection/deprotection cycles that demand total control of side reactions and residual bromide levels. Strict documentation and traceability support full lifecycle auditing from initial kilo-lab trials to cGMP commercial scale. Typical production lines integrate this material directly into multi-step organic syntheses on dedicated API lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Crop Protection Intermediate ManufacturingLeading agrochemical producers process 2-Bromo-4-Hydroxymethylthiazole as an electrophilic building block to create pre-emergence herbicide actives and fungicide scaffolds. Its reactivity supports thiazole-thioether and arylation coupling stages typically used in proprietary crop protection molecules. Traceability over halogen impurity and moisture levels are imperative for downstream toxicological compliance and stability of formulated products. Our controlled reaction environment preserves reactivity while minimizing unwanted side products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Dye Intermediate ProductionLeading dye and pigment plants incorporate 2-Bromo-4-Hydroxymethylthiazole in the synthesis of conductive thiazole-based dyes for application in electronics-grade inks and advanced textile printing. Process engineers select this intermediate to introduce bromo-activated points for subsequent azo or coupling chemistry, supporting color fastness and molecular stability in severe operational environments. Material quality is controlled for low inorganic salt content and batch spectral purity required by end markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Medicine Intermediate SynthesisProducers of veterinary active substances deploy 2-Bromo-4-Hydroxymethylthiazole as a high-purity ring precursor during the synthesis of anti-parasitic actives and anthelmintic candidates. Veterinary formulators enforce trace bromide and process solvent controls, aiming for safe final residue levels in animal-targeted formulations compliant with international veterinary pharmacopeial guidelines. Dedicated process lines prevent cross-contamination risk with human drug APIs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Reference Standard PreparationReference laboratories and standard-producing entities commission 2-Bromo-4-Hydroxymethylthiazole for custom synthesis of purity markers, metabolite tracking compounds, and analytical reference standards. Advanced purification steps—such as preparative HPLC or recrystallization—ensure certified reference material status, supporting ISO and pharmacopoeial method validation across pharmaceutical and research settings, where strict trace impurity limits apply. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Bromo-4-Hydroxymethylthiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For years, industry conversations about thiazole building blocks focus on reactivity, safety, and clean handling. Bringing a molecule like 2-Bromo-4-Hydroxymethylthiazole to the bench changes the landscape for process chemists and R&D teams. Producing this compound straight from raw intermediates in-house means a firm grip on consistency and tight property control across each lot.
Producing 2-Bromo-4-Hydroxymethylthiazole (CAS 870-73-1) day in and day out gives our technical team a front-row seat to the quirks of its chemistry. From the first bromination step to the last distillation, knowing how sensitive this molecule is to trace water and thermal degradation informs our manufacturing choices. We’ve kept our standard purity above 98%, spotting the off-odors or tints that can point to side-products long before analytical confirmation comes in.
Every batch poured from the reactor carries the same white-to-pale yellow crystalline character. Batch-to-batch color and texture fluctuations get reviewed, not dismissed. If something shifts, we investigate: solvent residues, changes in crystal growth, even the temperature ramp rate coming off the vacuum. Teams working with harsh bases or strong nucleophiles prefer a solid, reliable intermediate — that means our process avoids variable particle sizes or clumping.
Real-world production means men in boots, not folks behind digital walls. We build physical safety into our plant design because thiazoles by nature demand care. This isn’t a molecule that likes the open air or metal catalysts with careless stirring. We handle it as if each gram supplies the core of a proprietary pharmaceutical. Line purges stay strict, inert gas cover stays on every tank, operators run fresh gloves, and our old-timers scent troubles even when the panel says “green.” A few tricks passed down the line: gentle drying draws, non-glass-lined vessels for extended holding, and full-spectrum traceability at every valve.
Scaling from a few hundred grams to several metric tons doesn't allow for shortcuts. If the specification calls for NMR and HPLC tracking, we deliver — for us, science never separates from production. A large biotech in Europe once challenged us for a repeat lot with “no off-color, no odors, and no oiling out,” right as winter shipping hit. We held the lot three days longer, dialed the temperature window, and waited out the moisture. Result: a product that dropped out of solution crisp and white as the morning snow.
Molecular intermediates like 2-Bromo-4-Hydroxymethylthiazole see wide use in active pharmaceutical ingredient (API) synthesis and advanced intermediates for crop protection actives or diagnostic compounds. Success in these fields calls for high selectivity, minimal by-products, and confidence in upscaling. Our chemists plan for real-world buyers with plenty at stake: failed lots ripple downstream into missed campaigns, delayed filings, regulatory headaches. Every bug we’ve ironed out—say, during raw material shortages or transportation bottlenecks—plays a part in your success.
Customers tell us batch timing matters as much as paperwork. Many insist on direct feedback, real photos of final vials, hands-on tracking of every package, and open lines to our QC staff. Reports and COA files come with every sale, but the trust builds out of demonstrated delivery, transparency, and picking up the phone at odd hours. Working as the actual manufacturer, we field customer requests for adjusted melting point ranges, reduced moisture, or tweaked particle morphology without going back to any unrelated or virtual supplier.
2-Bromo-4-Hydroxymethylthiazole enters the critical step of many syntheses for thiazole-based drugs and specialty ligands. In labs, chemists rely on it as an alkylation and halogenation intermediate, plugging the bromo-methyl position into cross-coupling reactions, Suzuki or Buchwald–Hartwig chemistry, and C–H activation studies. The high bromo reactivity cuts down on unnecessary steps, accelerating route scouting and library expansion for those chasing patentable analogs.
Diagnostics companies and agrochemical teams favor our grade for its low residual starting material and stable shelf life. In the past, customers ran into bottlenecks with other sources, watching slow shipment clearance or getting material packed with sticky fines or abnormal moisture. These problems lead to downstream clean-up steps or, worse, off-target reactivity that tanks lab productivity. We’ve scrutinized each cause, working out tighter sieve protocol, short-path drying, and packaging under blanket nitrogen to minimize risks.
Many ask what sets apart a genuine factory product from standard trader goods. Several small ways add up: as the one running the reactors, we lock in raw material sourcing and lot tracking. There’s no swapping out for “commercial equivalent,” risking unmonitored impurity spikes or ambiguous analytical traces. Our QC packs run each batch through multiple chromatographic and spectroscopic analyses, with clear documentation for downstream traceability. The final product lands in tamper-evident packaging, each labeled by actual batch date and production record so nothing drifts off standard.
Handling details matter most. Fine bromo-thiazoles don’t behave well in poorly sealed containers — market resellers sometimes repack in “convenient” plastic, which pulls trace solvent residues from surrounding air, causing color or aroma changes. We stick with pre-tested liner systems and our own label adhesives, which many users recognize on sight. By fixing the packing line after repeated field feedback, we weeded out sources of cross-contamination and downtime.
As a real producer, if a user calls to ask for more aggressive technical support, an MSDS file, or extended documentation for regulatory filing, our team stands ready with lab records and batch-specific information. There’s no waiting for international emails or “we’ll check with the factory”—we are the factory, and the buck stops at our QA desk. Every time a researcher runs a reaction late at night and something doesn’t look right, direct email or a phone call often brings an answer within hours, supported by people who handle the actual molecule day after day.
Experienced scientists know that scalable access to robust thiazole intermediates streamlines new route development. Our 2-Bromo-4-Hydroxymethylthiazole brings both the purity and the predictable behavior that lets chemists plan with fewer surprises. One customer noted that their earlier suppliers provided material that left behind persistent bromo-smell residues and micro-fines that clumped into the next reaction. By managing each link of the process—synthesis, crystallization, drying, and packing—our team delivered a product that solved those costly quirks.
The competitive edge relies on both science and responsiveness. In mid-scale pharma syntheses, route reproducibility fuels regulatory filings and scale-up success. Any process hiccup—variability in melting point, unexpected off-color, excess fines—turns into a day lost in a busy pilot facility. We designed our reactor loads and recrystallization parameters to flatten out those challenges. This means our product comes off at the same physical property range every cycle, ready for direct use in gloveboxes or automated feed systems.
A decade ago, minor intermediates often came to global labs through networks of traders. Today, regulatory pressure, patent deadlines, and speed-to-market priorities mean delays cost millions. Many of our buyers operate under tight inventory windows, so lead times and contingency stocks carry serious weight. In recent years, logistics disruptions and raw material price jumps forced many traders to short supply, cut corners, or shift to substitute products. Direct factory supply, backed by our in-house inventory and commitment, closed off those weak points for our clients.
More than once, we’ve stepped up when spurts in demand hit—doubling output on critical timelines, keeping safety stock in nitrogen-packed drums, or expediting customs paperwork with tracked release. One of our process managers recalls hand-delivering critical kilograms for a European customer who faced a sudden regulatory review. Only with direct plant record and chain-of-custody could we guarantee the documentation and tested batch origin needed for formal compliance.
Nearly every advanced chemistry project starts with a contract, progress meetings, and a stack of certificates. In real-world manufacturing, what matters more is seeing material that matches the fingerprint of last year’s batch, knowing production history, and getting an answer on specification drift with a single phone call. Each 2-Bromo-4-Hydroxymethylthiazole production cycle brings insights that drive future process tweaks. We keep batch records tight, encourage feedback from real users, and bring lab results into the plant floor huddles.
Some buyers now demand not just analytical data, but photos of each lot, storage facility tours, and access to staff who know the quirks of every vessel and dryer. While not every producer brings that level of transparency, we encourage open discussion, audits, and technical support throughout the supply chain. Our own success depends on customers not just coming back, but sharing where our material made their work possible—or where it could see further improvement.
Researchers in pharma, fine chemicals, and diagnostics value 2-Bromo-4-Hydroxymethylthiazole for its consistent performance in terminal bromination, selective halogen introduction, and late-stage functionalization. Its robust reactivity profile, paired with thermal and chemical stability, reduces risk during critical steps such as coupling or alkylation. Technical teams appreciate that the material runs through automated feeders smoothly and can be stored with predictable behavior under inert conditions.
Older grades from trading houses sometimes brought uneven sizes, oily residue, or off-odor—issues that knock out entire process runs in high-sensitivity synthesis. By keeping our particle size spectrum tight and removing volatile by-products through multi-stage drying, we help labs avoid the wasted hours spent on rescrystallization or trouble-shooting unexplained off-target reactions. Large buyers who demand uninterrupted process runs count on our supply chain controls: physical site security, monitored shipment, and documentation that stands up to any audit.
One crop science firm ramped up their analog program and faced repeated delays from marketplace bottlenecks. Shortages in thiazole intermediates risked holding back multistage syntheses, with deadline pressure mounting. Our in-house production lines adjusted recipe scales on short notice, maintained batch consistency, and stood by for evening shipment releases—delivering not just the product, but a rapid troubleshooting response team with field-tested insight.
Customers in analytical labs often specify maximum moisture thresholds or UV-purity requirements unique to diagnostic tags. Each request brings new process refinement. Sometimes we tweak drying pressures, change filter media, or adjust crystal growth rate based on direct user input. Our teams work closely with these specialists, feeding back practical findings to production and keeping the spec current not just for one customer, but for the whole field.
Looking at the market, you’ll see a range of bromo-thiazole derivatives—2-bromothiazole, 2-bromomethylthiazole, and 2-bromo-4-methylthiazole make frequent appearances on chemical lists. The unique value in 2-Bromo-4-Hydroxymethylthiazole lies in its dual activation: both the bromo and hydroxymethyl functionalities drive orthogonal coupling routes, expanding what’s possible for structure diversification. Where comparable molecules bring only limited branching or introduce instability under heat or light, this compound maintains backbone rigidity while permitting highly selective derivatization across multistep campaigns.
We’ve produced and compared competing thiazoles side-by-side. This molecule outperforms leaner structures in dual-functionalized library build-outs where minimizing by-products and streamlining purification takes priority. Its relative thermal stability and storage profile allow even small labs to maintain supplies for longer use windows, minimizing waste or urgent re-orders from halfway across the globe.
Chemistry moves fast—today’s critical intermediate can become tomorrow’s bottleneck if sourcing and quality slip. Running the day-to-day for a specialty product like 2-Bromo-4-Hydroxymethylthiazole means riding herd on every part of its journey: from milligram-scale pilot studies to full production runs, from moisture control on a rainy dock to batch records checked by regulatory auditors. Our staff stands by each shipment, knowing these grams close patent routes, power breakthrough diagnostics, or shield the food chain through crop science innovation.
Years of making this molecule have taught us the value of direct feedback and real accountability. Problems don’t get solved by brochure text—they get solved by people who know the chemistry inside every tank, who recognize critical details, and who care about your outcome as much as theirs. That’s what defines our product, and that’s what partners across the sciences continue to look for as innovation accelerates the need for reliability in every bottle.